Logo image of CON

CONCENTRA GROUP HOLDINGS PAR (CON) Stock Fundamental Analysis

NYSE:CON - New York Stock Exchange, Inc. - US20603L1026 - Common Stock - Currency: USD

22.96  -0.45 (-1.92%)

After market: 22.96 0 (0%)

Fundamental Rating

3

CON gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 108 industry peers in the Health Care Providers & Services industry. CON has a medium profitability rating, but doesn't score so well on its financial health evaluation. CON has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year CON was profitable.
CON Yearly Net Income VS EBIT VS OCF VS FCFCON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 200M 400M 600M

1.2 Ratios

CON's Return On Assets of 13.10% is amongst the best of the industry. CON outperforms 95.33% of its industry peers.
CON's Return On Equity of 116.99% is amongst the best of the industry. CON outperforms 98.13% of its industry peers.
The Return On Invested Capital of CON (21.33%) is better than 97.20% of its industry peers.
Industry RankSector Rank
ROA 13.1%
ROE 116.99%
ROIC 21.33%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CON Yearly ROA, ROE, ROICCON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 10 20 30

1.3 Margins

CON has a Profit Margin of 9.93%. This is amongst the best in the industry. CON outperforms 93.46% of its industry peers.
With an excellent Operating Margin value of 16.34%, CON belongs to the best of the industry, outperforming 94.39% of the companies in the same industry.
CON has a Gross Margin of 28.11%. This is comparable to the rest of the industry: CON outperforms 54.21% of its industry peers.
Industry RankSector Rank
OM 16.34%
PM (TTM) 9.93%
GM 28.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CON Yearly Profit, Operating, Gross MarginsCON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 5 10 15

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CON is creating value.
Compared to 1 year ago, CON has about the same amount of shares outstanding.
Compared to 1 year ago, CON has an improved debt to assets ratio.
CON Yearly Shares OutstandingCON Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 20M 40M 60M 80M 100M
CON Yearly Total Debt VS Total AssetsCON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

CON has an Altman-Z score of 2.91. This is not the best score and indicates that CON is in the grey zone with still only limited risk for bankruptcy at the moment.
CON has a Altman-Z score of 2.91. This is in the better half of the industry: CON outperforms 65.42% of its industry peers.
A Debt/Equity ratio of 5.30 is on the high side and indicates that CON has dependencies on debt financing.
CON has a worse Debt to Equity ratio (5.30) than 84.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.3
Debt/FCF N/A
Altman-Z 2.91
ROIC/WACC2.38
WACC8.97%
CON Yearly LT Debt VS Equity VS FCFCON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 200M 400M 600M 800M 1B

2.3 Liquidity

CON has a Current Ratio of 1.52. This is a normal value and indicates that CON is financially healthy and should not expect problems in meeting its short term obligations.
CON has a Current ratio of 1.52. This is comparable to the rest of the industry: CON outperforms 54.21% of its industry peers.
A Quick Ratio of 1.52 indicates that CON should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.52, CON is in line with its industry, outperforming 55.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 1.52
CON Yearly Current Assets VS Current LiabilitesCON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 50M 100M 150M 200M 250M

More info and screens

1

3. Growth

3.1 Past

CON shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.93%.
CON shows a small growth in Revenue. In the last year, the Revenue has grown by 6.60%.
EPS 1Y (TTM)7.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)6.6%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

CON is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -18.90% yearly.
The Revenue is expected to decrease by -15.96% on average over the next years. This is quite bad
EPS Next Y-50.44%
EPS Next 2Y-32.34%
EPS Next 3Y-18.9%
EPS Next 5YN/A
Revenue Next Year-47.8%
Revenue Next 2Y-25.12%
Revenue Next 3Y-15.96%
Revenue Next 5YN/A

3.3 Evolution

CON Yearly Revenue VS EstimatesCON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 1B 2B 3B
CON Yearly EPS VS EstimatesCON Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.5 1 1.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.60, which indicates a very decent valuation of CON.
Based on the Price/Earnings ratio, CON is valued cheaply inside the industry as 95.33% of the companies are valued more expensively.
CON's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.63.
The Price/Forward Earnings ratio is 17.64, which indicates a rather expensive current valuation of CON.
CON's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CON is cheaper than 69.16% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.68. CON is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 8.6
Fwd PE 17.64
CON Price Earnings VS Forward Price EarningsCON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CON is valued cheaply inside the industry as 88.78% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.12
CON Per share dataCON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

CON's earnings are expected to decrease with -18.90% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-32.34%
EPS Next 3Y-18.9%

More info and screens

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.10%, CON has a reasonable but not impressive dividend return.
CON's Dividend Yield is rather good when compared to the industry average which is at 2.95. CON pays more dividend than 82.24% of the companies in the same industry.
With a Dividend Yield of 1.10, CON pays less dividend than the S&P500 average, which is at 2.29.
Industry RankSector Rank
Dividend Yield 1.1%

5.2 History

CON does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CON Yearly Dividends per shareCON Yearly Dividends per shareYearly Dividends per share 2024 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

DPN/A
EPS Next 2Y-32.34%
EPS Next 3Y-18.9%
CON Yearly Income VS Free CF VS DividendCON Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

CONCENTRA GROUP HOLDINGS PAR

NYSE:CON (2/21/2025, 8:10:34 PM)

After market: 22.96 0 (0%)

22.96

-0.45 (-1.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-31 2024-10-31/amc
Earnings (Next)03-03 2025-03-03
Inst Owners4.87%
Inst Owner Change296.98%
Ins OwnersN/A
Ins Owner Change-1445.28%
Market Cap2.92B
Analysts81.67
Price Target27.98 (21.86%)
Short Float %2.49%
Short Ratio3.15
Dividend
Industry RankSector Rank
Dividend Yield 1.1%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.11%
Min EPS beat(2)1.03%
Max EPS beat(2)3.19%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.29%
Min Revenue beat(2)-1.59%
Max Revenue beat(2)-0.99%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.52%
PT rev (3m)-4.95%
EPS NQ rev (1m)1.95%
EPS NQ rev (3m)3.61%
EPS NY rev (1m)0.27%
EPS NY rev (3m)0.72%
Revenue NQ rev (1m)0.44%
Revenue NQ rev (3m)0.55%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.16%
Valuation
Industry RankSector Rank
PE 8.6
Fwd PE 17.64
P/S 0.89
P/FCF N/A
P/OCF N/A
P/B 10.53
P/tB N/A
EV/EBITDA 7.12
EPS(TTM)2.67
EY11.63%
EPS(NY)1.3
Fwd EY5.67%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS25.7
BVpS2.18
TBVpS-9.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.1%
ROE 116.99%
ROCE 24.19%
ROIC 21.33%
ROICexc 22.73%
ROICexgc 74.77%
OM 16.34%
PM (TTM) 9.93%
GM 28.11%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 5.3
Debt/FCF N/A
Debt/EBITDA 2.42
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.52
Quick Ratio 1.52
Altman-Z 2.91
F-ScoreN/A
WACC8.97%
ROIC/WACC2.38
Cap/Depr(3y)71.42%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.52%
Cap/Sales(5y)N/A
Profit Quality(3y)129.88%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-50.44%
EPS Next 2Y-32.34%
EPS Next 3Y-18.9%
EPS Next 5YN/A
Revenue 1Y (TTM)6.6%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-47.8%
Revenue Next 2Y-25.12%
Revenue Next 3Y-15.96%
Revenue Next 5YN/A
EBIT growth 1Y11.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-34.21%
EBIT Next 3Y-7.97%
EBIT Next 5YN/A
FCF growth 1Y-20.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.59%
OCF growth 3YN/A
OCF growth 5YN/A